Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.68
0.20 (13.51%)
At close: Aug 15, 2025, 12:53 PM

Zentalis Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
67.42M n/a n/a n/a
Cost of Revenue
1.29M 1.39M 1.43M 544K
Gross Profit
67.42M -1.39M -1.43M -544K
Operating Income
-191.19M -253.94M -227.29M -216.54M
Interest Income
n/a n/a 2.26K 1.31K
Pretax Income
-165.69M -292.91M -221.3M -164.56M
Net Income
-165.84M -292.19M -236.81M -158.72M
Selling & General & Admin
87.11M 59.4M 54.55M 40.94M
Research & Development
167.77M 189.59M 172.73M 175.6M
Other Expenses
3.74M 3.56M n/a n/a
Operating Expenses
258.62M 252.55M 227.29M 216.54M
Interest Expense
n/a n/a 2.58M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
258.62M 253.94M 227.29M 216.54M
Income Tax Expense
177K -601K -469K -297K
Shares Outstanding (Basic)
71.08M 65.41M 52.86M 42.69M
Shares Outstanding (Diluted)
71.08M 65.41M 52.86M 42.69M
EPS (Basic)
-2.33 -4.47 -4.48 -3.72
EPS (Diluted)
-2.33 -4.47 -4.48 -3.72
EBITDA
-186.17M -275.5M -219.87M -164.01M
EBIT
-187.46M -276.89M -221.3M -164.56M
Depreciation & Amortization
1.29M 1.39M 1.43M 544K